The Oral Insulin Sensitizer, Thiazolidinedione, Increases Plasma Vascular Endothelial Growth Factor in Type 2 Diabetic Patients
Diabetes Care - United States
doi 10.2337/diacare.24.5.953
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2001
Authors
Publisher
American Diabetes Association